Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Williams-Sonoma, Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Williams-Sonoma, Inc. trades at $235.65 (market cap $28.32B). The key difference: Williams-Sonoma, Inc. is far larger — about 6× Definium Therapeutics Inc. Common Shares's market cap, and Williams-Sonoma, Inc. pays a 1.26% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Williams-Sonoma, Inc. for 59 Days on average.
| DFTX | WSM | |
|---|---|---|
Market Cap | $4.71B | $28.32B |
Volume | 1,966,636 | 963,190 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $251.81 |
52-Week Low | $10.68 | $168.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $3.67B | $28.82B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Williams-Sonoma (WSM) trades at $239.00, down 1.35% on the day, with strong technical momentum showing bullish moving averages despite overbought RSI readings. The company demonstrates robust fundamentals with 14.73% net income margin and consistent earnings beats, having exceeded expectations in three consecutive quarters. Recent news highlights the company's market share gains and AI integration driving operational efficiency.
The outlook remains positive with a consensus price target of $246.31 representing 3% upside potential. Key opportunities include sustained margin expansion and business-to-business growth, while risks involve housing market sensitivity and competitive pressures in the home furnishings sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
